Dazhuo Shi

XS0601 reduces the incidence of restenosis: a prospective study of 335 patients undergoing percutaneous coronary intervention in China

Keji Chen, Dazhuo Shi, Hao Xu et al. · Chinese Medical Journal · 2006 · 65 citations · Full text

A multi-center randomized double-blind placebo-controlled trial of Xiongshao Capsule (芎芍胶囊) in preventing restenosis after percutaneous coronary intervention: A subgroup analysis of senile patients

Qinghua Shang, Hao Xu, Xiaoyan Lu et al. · Chinese Journal of Integrative Medicine · 2011 · 36 citations

Percutaneous Coronary Intervention, Senile Patients, Cardiovascular Disease +9

Xinyue Capsule in patients with stable coronary artery disease after percutaneous coronary intervention: a multicenter, randomized, placebo-controlled trial

Ming Guo, Peili Wang, Jianpeng Du et al. · Pharmacological Research · 2020 · 30 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Clinical Trials +7

Resting heart rate associates with one-year risk of major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention

Shao-Li Wang, Chenglong Wang, Peili Wang et al. · Experimental Biology and Medicine · 2015 · 25 citations · Full text

Synergistic protection of Danhong Injection (丹红注射液) and ischemic postconditioning on myocardial reperfusion injury in minipigs

Xiaojuan Ma, Shang‐Jun Yin, Jin Ji-cheng et al. · Chinese Journal of Integrative Medicine · 2010 · 24 citations

Danhong Injection, Cardiogenic Shock, Cardiovascular Disease +9